HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fungi Perfecti Earns Ostrom's 110% Positive Status In Example Of Systemic Sustainability Approach

Executive Summary

Fungi Perfecti made pledge to reduce its carbon footprint and partnered with Ostrom Climate to calculate its emissions by Greenhouse Gas Protocol Corporate Standard’s three scopes. Annika Greve, director of TerraCycle's Loop North America business development, says “it’s not about getting it perfect, but about starting."

You may also be interested in...



Seed Health Extends Synbiotic Supplement Line For GI Health To Children’s Daily

Seed Health launches PDS-08 daily probiotic and fiber supplement for children and adolescents. Company says it has achieved climate-positive status through recyclable and compostable packaging and investments in carbon offset projects.

Amazon Becomes ‘Aware,’ Launches Own Eco-Certified Skin-Care And Other Offerings

Amazon is expanding its private-label beauty portfolio with the rollout of Amazon Aware, an ‘everyday essentials’ collection comprising skin care, home and apparel items certified in accordance with its Climate Pledge Friendly program.

Bayer Invests €100m Into Making Consumer Heath Brands Sustainable

Bayer is reinvesting 2% of its Consumer Health division’s sales to drive the sustainable use of the company’s OTC brands and “help create a world where people can live healthier lives.”

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152341

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel